Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma

NCT00972335 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped Study terminated early due to slow accrual

Conditions

Intracranial Meningioma

Interventions

DRUG: Everolimus
DRUG: Bevacizumab

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]